Novel compounds having selective inhibiting effect at GSK3

Details for Australian Patent Application No. 2003287135 (hide)

Owner AstraZeneca AB

Inventors Berg, Stefan; Soderman, Peter; Hellberg, Sven

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003287135

PCT Number PCT/SE2003/0019

PCT Pub. Number WO2004/055005

Priority 0203754-7 17.12.02 SE

Filing date 15 December 2003

Wipo publication date 9 July 2004

Acceptance publication date 25 January 2007

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/48 (2006.01) Drugs for disorders of the endocrine system

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 0203754-7 17.12.02 SE

19 August 2004 Application Open to Public Inspection

  Published as AU-B-2003287135

25 January 2007 Application Accepted

  Published as AU-B-2003287135

24 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287136-NOBEL COMPOUNDS HAVING SELECTIVE INHIBITING EFFECT AT GSK3

2003287134-SKIN PENETRATION DEVICE TO SIMULTANEOUSLY INTRODUCE A PLURALITY OF SUBSTANCES